Price Chart

Executive Summary

Medtronic has formally launched an exchange offer to split off its remaining ~89.86% stake in MiniMed (MMED), offering up to 225,361,295 MiniMed shares in exchange for MDT shares at a ~7.5% premium ($107.53 of MMED per $100 of MDT). The offer expires October 9, 2026, and is expected to be tax-free under Section 355. This is a routine procedural milestone in the separation process announced in May 2025 — no new financial data, no opposition, and no changes to deal terms. The filing is informational only and does not alter Medtronic's standalone outlook.

Key Financial Metrics

Key Facts

• Medtronic is offering up to 225,361,295 newly issued MiniMed shares (80.1% of MMED) in exchange for MDT shares at a ~7.5% premium ($107.53 of MMED per $100 of MDT).
• If oversubscribed, Medtronic may accept an additional 27,452,053 MMED shares (the De Minimis Increase Amount), divesting its full 89.9% stake.
• The exchange ratio is based on 3-day VWAP averaging (Oct 5-7, 2026), with an upper limit of 4.5939 MMED shares per MDT share (a 12% discount floor).
• The offer expires October 9, 2026; shareholders can withdraw tendered shares anytime before expiration.
• The transaction is expected to be tax-free under Section 355 of the Internal Revenue Code.
• Medtronic will redeem and cancel all MDT shares acquired in the exchange, reducing share count without using cash.
• MiniMed does not expect to pay dividends for the foreseeable future.
• Conditions include minimum tender of 112,680,647 MMED shares and receipt of a tax opinion from Skadden.

Financial Impact

Medtronic will reduce its outstanding share count by up to ~49 million shares (at a 4.5939 exchange ratio) without cash outlay. The net book value difference vs. market value will be recognized as a gain or loss on disposal.

Risk Factors

• Exchange offer may be undersubscribed, leaving Medtronic with a residual ~9.76% stake requiring a separate clean-up divestment.
• Upper limit on exchange ratio could reduce the effective premium if MMED underperforms MDT during the averaging period.
• Market disruption events could delay or terminate the offer.
• The registration statement (S-4) has not yet been declared effective by the SEC, delaying completion.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 16 SEC documents filed with EDGAR.

US Market Status

Related Tickers